Results 31 to 40 of about 76,925 (188)

Treatment recommendations for psoriatic arthritis [PDF]

open access: yes, 2008
Objective: To develop comprehensive recommendations for the treatment of the various clinical manifestations of psoriatic arthritis (PsA) based on evidence obtained from a systematic review of the literature and from consensus opinion.
Ritchlin, CT   +15 more
core   +1 more source

TNF-α gene expression in immune cells of patients with psoriasis and psoriatic arthritis

open access: yesМедицинский совет, 2022
Introduction. Psoriatic disease is a heterogeneous inflammatory disease with different clinical manifestations, including plaque psoriasis and psoriatic arthritis.
V. V. Sobolev   +5 more
doaj   +1 more source

Immune-mediated inflammation promotes subclinical atherosclerosis in recent-onset psoriatic arthritis patients without conventional cardiovascular risk factors [PDF]

open access: yes, 2018
Studies on the inflammatory burden in recent-onset psoriatic arthritis (PsA) patients without conventional cardiovascular risk factors (CVRFs) are not available.
Capani, Francisco   +8 more
core   +1 more source

Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis [PDF]

open access: yes, 2016
Systemic biomarkers of oxidative stress can be relevant for assessment of psoriasis severity, for prediction of the outcome of therapy and of the development of comorbidities.
Cavaliere, Arturo   +2 more
core   +2 more sources

Genetic markers for psoriatic arthritis among patients with psoriasis. Part II: HLA genes [PDF]

open access: yesVestnik Dermatologii i Venerologii, 2021
Psoriatic arthritis often leads to the development of severe outcomes ankylosis, deformities of the affected joints with severe impairment of their functions and disability.
A. A. Kubanov   +5 more
doaj   +1 more source

TCD4pos lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agents [PDF]

open access: yes, 2017
BACKGROUND: Lymphocyte expansion and true lymphocytosis are commonly observed in the everyday clinical practice. The meaning of such phenomenon is often poorly understood so that discrimination between benign and malignant lymphocytosis remains ...
Amodeo, Rachele   +11 more
core   +1 more source

Psoriatic Arthritis and Diabetes: A Population-Based Cross-Sectional Study

open access: yesDermatology Research and Practice, 2013
Background. Diabetes has been associated with psoriasis, but little is known about the association between psoriatic arthritis and diabetes. Methods. Patients diagnosed with psoriatic arthritis by a rheumatologist were compared to age- and sex-matched ...
Jacob Dreiher   +2 more
doaj   +1 more source

Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study [PDF]

open access: yes, 2013
Objectives: To assess long-term golimumab efficacy/safety in patients with active psoriatic arthritis (PsA).<p></p> Methods Adult PsA patients (≥3 swollen, ≥3 tender joints, active psoriasis) were randomly assigned to ...
Beutler, A.   +10 more
core   +1 more source

Challenges in the Metabolomics-Based Biomarker Validation Pipeline

open access: yesMetabolites
As end-products of the intersection between the genome and environmental influences, metabolites represent a promising approach to the discovery of novel biomarkers for diseases.
Shenghan Li   +3 more
doaj   +1 more source

Identification of a Single Nucleotide Polymorphism in NFKBIA with Different Effects on Psoriatic Arthritis and Cutaneous Psoriasis in China

open access: yesActa Dermato-Venereologica, 2018
Genome-wide association studies have recently identified a number of non-major histocompatibility complex regions associated with psoriatic arthritis.
Qing Zhao   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy